TCS buys Porsche’s MHP for €320m and lands a €1.25bn contract with it
THE SO WHAT
Porsche offloading MHP for €320m while signing a €1.25bn, five-year engagement with TCS is a clean example of OEMs swapping in-house consulting for long-term AI and IT services partnerships. If you’re an industrial or auto player, expect more pressure to decide what stays as captive digital capability versus what you externalize to global integrators.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureValor, Point72 back General Intuition at $6B valuation as AI startup pushes into robotics
A $6B pre-money for a foundation model focused on teaching agents to move through space and time says capital is now betting that embodied intelligence will be its own stack, not just a sidecar to LLMs. If you’re building in robotics or industrial automation, assume a world where motion policy, not just language, is a platform dependency—and start mapping where you want to own vs. rent that layer.
Startups & VentureUS nutrition startup Berry Street merges with India’s Healthify as GLP-1 trends upwards
A US–India merger around GLP-1-driven nutrition is a bet that weight-loss drugs will structurally change how consumers engage with food and coaching. Health and wellness startups should be modeling cross-border consolidation and partnerships now, before pharma and payers lock up the distribution rails.
Startups & VentureMinimus, a cybersecurity startup started by Twistlock founders, shuts down after failing to gain enough commercial momentum; Minimus raised a $51M seed in 2023
A $51M seed-stage security company failing to find traction is a warning that brand and pedigree no longer guarantee product–market fit, even in "hot" categories. Security buyers are saturated—if your value prop doesn’t clearly replace or consolidate existing tools, expect long cycles and hard noes.
Startups & VentureStartups Are Still Acquiring Startups, Led By Ultra-High-Valuation Unicorns
Unicorns using cash and stock to buy smaller startups — especially for AI, fintech, and biotech capabilities — means acqui-build is now the default for filling product gaps under time pressure. Founders should design for being either a buyer or a clean bolt-on: modular tech, clear IP, and focused teams that can be integrated quickly.